✦ LIBER ✦

346 Taxol or doxorubicin as first line chemotherapy in advanced breast cancer (ABC). A prospective randomized phase II study with crossover

✍ Scribed by R. Paridaens; P. Bruning; F. Calabresi; A. Awada; J.A. Roy; Z. Kusenda; M. Piccart

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

645 - Taxol (T) versus doxorubicin (D) a

✍ R. Paridaens; P. Bruning; J. Klljn; T. Gamucci; L. Biganzoli; A. Van Vreckem; G. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 280 KB

Phase II trial with navelbine (NVB) in a

✍ Lluch, A.; Cervantes, A.; Cervera, V.; Casado, A.; García-Conde, J.; Martín, M.; 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Results of a phase II study of pemetrexe

✍ Nicholas J. Robert; Paul R. Conkling; Mark A. O’Rourke; Paul R. Kuefler; Kristi 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 234 KB

81 P - Epirubicin (EPI) + navelbine (NVB

✍ E. Baldini; C. Tibaldi; M. Da Prato; A. Chiavacci; M. Di Lielo; R. Taviani; P. G 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 130 KB

A phase II study of oral vinorelbine (NV

✍ V. Trillet-Lenoir; T. Delozier; M. Lichinister; D. Gédouin; P. Bougnoux 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 334 KB

A Phase II Randomized Crossover Study of

✍ Denise A. Yardley; Howard A. Burris III; David R. Spigel; Bobby L. Clark; Elizab 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 359 KB